Effects of altered food intake during pubertal development in male and female wistar rats.
The U.S. Environmental Protection Agency is currently validating assays that will be used in a Tier I Screening Battery to detect endocrine disrupting chemicals. A primary concern with the Protocols for the Assessment of Pubertal Development and Thyroid Function in Juvenile Male and Female Rats is that a nonspecific reduction in body weight (BWT) during the exposure period may potentially confound the interpretation of effects on the endocrine endpoints. Wistar rats were underfed 10, 20, 30, or 40% less than the ad libitum food consumed by controls from postnatal days (PNDs) 22 to 42 (females) or PNDs 23 to 53 (males). Terminal BWT of females and males were 2, 4, 12, and 19% and 2, 6, 9, and 19% lower than controls, respectively. In the females, neither the age of pubertal onset nor any of the thyroid hormone endpoints were affected by food restriction (FR) that led to a 12% decrease in BWT. Similarly, none of the male reproductive endpoints examined were altered by FR that led to a 9% BWT decrease. However, decreased triiodothyronine and thyroxin was observed in FR males with a 9% reduced BWT. While these data support the use of the maximum tolerated dose for BWT (10%) for the female protocol, effects on the male thyroid endpoints indicate that a slightly lower limit (<or= 6% BWT loss) may be appropriate for the male pubertal protocol, and in cases where the BWT loss approaches 9-10%, additional studies and/or a weight of evidence approach should be used when interpreting the data for the thyroid endpoints.
Laws
Susan C
SC
National Health and Environmental Effects Research Laboratory, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina 27711, USA. laws.susan@epa.gov
Stoker
Tammy E
TE
Ferrell
Janet M
JM
Hotchkiss
Michelle G
MG
Cooper
Ralph L
RL
D000311:Adrenal Glands / Q000254:growth & development; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D001835:Body Weight / Q000187:drug effects*; D052244:Endocrine Disruptors / Q000633:toxicity*; D005260:Female; D005508:Food Deprivation; D005836:Genitalia, Female / Q000254:growth & development; D005837:Genitalia, Male / Q000254:growth & development; D007668:Kidney / Q000254:growth & development; D020738:Leptin / Q000097:blood; D008099:Liver / Q000254:growth & development; D008297:Male; D009929:Organ Size; D010902:Pituitary Gland / Q000254:growth & development; D051381:Rats; D017208:Rats, Wistar; D015203:Reproducibility of Results; D012741:Sexual Maturation; D013961:Thyroid Gland / Q000254:growth & development; D013963:Thyroid Hormones / Q000097:blood; D018675:Toxicity Tests / Q000379:methods* / Q000592:standards; D014621:Vagina / Q000254:growth & development; D015431:Weight Loss
D001786:Blood Glucose; D052244:Endocrine Disruptors; D020738:Leptin; D013963:Thyroid Hormones